Role of c-jun N-terminal protein kinase 1/2 (JNK1/2) in macrophage-mediated MMP-9 production in response to Moraxella catarrhalis Lipooligosaccharide (LOS)

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Hassan, Ferdaus ^a,b   Ren, Dabin ^a,c   Zhang, Wenhong ^a,d   Gu, Xin Xing ^a,e  

^a NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^c MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES   (China)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; GELATINASE B; LIPOOLIGOSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 9; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; BACTERIAL ANTIGEN; LIPID LINKED OLIGOSACCHARIDES; LIPID-LINKED OLIGOSACCHARIDES; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; ENZYME SYNTHESIS; FEMALE; IN VITRO STUDY; MACROPHAGE; MORAXELLA CATARRHALIS; MOUSE; NONHUMAN; OTITIS MEDIA; PATHOGENESIS; PROTEIN EXPRESSION; ZYMOGRAPHY; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL LINE; HOST PATHOGEN INTERACTION; IMMUNOLOGY; MICROBIOLOGY; MORAXELLACEAE INFECTION; PHYSIOLOGY;

MORAXELLA CATARRHALIS; MURINAE; NEGIBACTERIA;

ANIMALS; ANTIGENS, BACTERIAL; CELL LINE; CELLS, CULTURED; FEMALE; HOST-PATHOGEN INTERACTIONS; LIPOPOLYSACCHARIDES; MACROPHAGES; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASE 9; MORAXELLA (BRANHAMELLA) CATARRHALIS; MORAXELLACEAE INFECTIONS;

EID: 84861414881     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037912     Document Type: Article

References (39)

1. Bondy J, Berman S, Glazner J, Lezotte D, (2000) Direct expenditures related to otitis media diagnosis: extrapolations from a pediatric Medicaid cohort. Pediatrics 105: e72.
2. Leibovitz E, Jacobs MR, Dagan R, (2004) Haemophilus influenzae: a significant pathogen in acute otitis media. Pediatr Infect Dis J 23: 1142-1152.
3. Faden H, Hong J, Murphy T, (1992) Immune response to outer membrane antigens of Moraxella catarrhalis in children with otitis media. Infect Immun 60: 3824-3829.
4. Ruuskanen O, Heikkinen T, (1994) Otitis media: etiology and diagnosis. Pediatr Infect Dis J 13:S23-26.discussion S50-24.
5. American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media (2004) Diagnosis and management of acute otitis media. Pediatrics 113: 1451-65.
6. Edebrink P, Jansson PE, Rahman MM, Widmalm G, Holme T, Rahman M, (1995) Structural studies of the O-antigen oligosaccharides from two strains of Moraxella catarrhalis serotype C. Carbohydr Res 266: 237-261.
7. Edebrink P, Jansson PE, Rahman MM, Widmalm G, Holme T, Rahman M, Weintraub A, (1994) Structural studies of the O-polysaccharide from the lipopolysaccharide of Moraxella (Branhamella) catarrhalis serotype A (strain ATCC 25238). Carbohydr. Res 257: 269-284.
8. Masoud H, Perry MB, Brisson JR, Uhrin D, Richards JC, (1994) Structural elucidation of the backbone oligosaccharide for the lipopolysaccharide of Moraxella catarrhalis serotype A. Can J Chem72: 1466-1477.
9. Newby AC, (2008) Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability. Arterioscler Thromb Vasc Biol 28: 2108-14.
10. Kessenbrock K, Plaks V, Werb Z, (2010) Matrix Metalloproteinases: Regulators of the Tumor Microenvironment. Cell 141: 52-67.
11. Moon SK, Linthicum FH Jr, Yang HD, Lee SJ, Park K, (2008) Activities of matrix metalloproteinases and tissue inhibitor of metalloproteinase-2 in idiopathic hemotympanum and otitis media with effusion. Acta Oto-Laryng 128: 144-150.
12. Jang CH, Shin SH, Cho HH, Moon SJ, Cho YB, (2006) Expression of matrix metalloproteinase-9 and-2 in pediatric chronic otitis media with effusion. Int J Pediatr Otorhinolaryngol 70: 1155-8.
13. Xie H, Gu XX, (2008) Moraxella catarrhalis lipooligosaccharide selectively upregulates ICAM-1 expression on human monocytes and stimulates adjacent naïve monocytes to produce TNF-α through cellular cross-talk. Cell Microbiol 10: 1453-67.
14. Chirco R, Liu XW, Jung Ky, Kim HC, (2006) Novel functions of TIMPs in cell signaling. Cancer Metastasis Rev 25: 99-113.
15. Unhanand M, Maciver I, Ramilo O, Arencibia-Mireles O, Argyle JC etal, (1992) Pulmonary clearance of Moraxella catarrhalis in an animal model. J Infect Dis 165: 644-650.
16. Gu XX, Chen J, Barenkamp SJ, Robbins JB, Tsai CMetal, (1998) Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis. Infect Immun 66: 1891-1897.
17. Meerpohl HG, Lohmann-Matthes ML, Fisher H, (1976) Studies on the activation of mouse bone marrow-derived macrophages by the macrophage cytotoxicity factor (MCF). Eur J Immunol. 6: 213-217.
18. Naiki Y, Michelsen KS, Zhang W, Chen S, Doherty TM, Arditi M, (2005) Transforming growth factor-beta differentially inhibits MyD88-dependent, but not TRAM- and TRIF-dependent, lipopolysaccharide-induced TLR4 signaling. J Biol Chem 280: 5491-5.
19. Vincenti MP, Brinckerhoff CE, (2007) Signal transduction and cell-type specific regulation of matrix metalloproteinase gene expression: Can MMPs be good for you? J Cell Physiology 213: 255-364.
20. Bain J, McLauchlan H, Elliott M, Cohen P, (2003) The specificities of protein kinase inhibitors: an update. Biochem. J. 371: 199-204.
21. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T, (2003) Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem; 253: 269-85.
22. Granström G, (2009) Middle ear infection. Periodontology 2000. 49: 179-193.
23. Bluestone CD, (1996) Pathogenesis of otitis media: role of Eustachian tube. Pediatr Infect Dis 15: 281-291.
24. Magnuson K, Hermansson A, Hellstrom S, (1996) Healing of tympanic membrane after myringotomy during Streptococcus pneumoniaeotitis media. An otomicroscopic and histologic study in the rat. Ann Otol Rhinol Laryngol 105: 397-404.
25. Magnuson K, Hellstrom S, (1994) Early structural changes in the rat tympanic membrane during pneumococcal otitis media. Eur Arch Otorhinolaryngol 251: 393-8.
26. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, et al. (1993) Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4: 197-250.
27. Wilmoth JG, Schultz GS, Antonelli PJ, (2003) Tympanic Membrane Metalloproteinase Inflammatory Response. Otolaryngol Head Neck Surg 129: 647-54.
28. Antonelli PJ, Schultz GS, Kim KM, Cantwell JS, Sundin DJ, Pemberton PA, et al. (2003) Alpha 1-antitrypsin and ilomastat inhibit inflammatory proteases present in human middle ear effusions. Laryngoscope.113: 1347-51.
29. Fomsgaard JS, Fomsgaard A, Hoiby N, Bruun B, Galanos C, (1991) Comparative immunochemistry of lipopolysaccharides from Branhamella catarrhalis strains. Infect. Immun. 59: 3346-3349.
30. Cargnello M, Roux PP, (2011) Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev 75: 50-83.
31. Woo CH, Lim JH, Kim JH, (2004) Lipopolysaccharide induces matrix metalloproteinase-9 expression via a mitochondrial reactive oxygen species-p38 kinase-activator protein-1 pathway in Raw 264.7 cells. J Immunol. 173: 6973-80.
32. Vincenti MP, (2001) The matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) genes. Transcriptional and posttranscriptional regulation, signal transduction and cell-type-specific expression. Methods Mol Biol 151: 121-148.
33. Schonermark M, Mester B, Kempf HG, Blaser J, Tschesche H, Lenarz T, (1996) Expression of matrix-metalloproteinases and their inhibitors in human cholesteatomas. Acta Otolaryngol. 116: 451-6.
34. Bogoyevitch MA, Authur PG, (2008) Inhibitors of c-Jun N-terminal kinases-JuNK no more? Biochimica et Biophysica Acta 1784: 76-93.
35. Gao Y, Signore AP, Yin W, Cao G, Yin XM, Sun F, (2005) Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis- signaling pathway. J Cereb Blood Flow Metab 25: 694-712.
36. Ishii M, Suzuki Y, Takeshita K, Miyao N, Kudo H, Hiraoka R, (2004) Inhibition of c-Jun NH2-terminal kinase activity improves ischemia/reperfusion injury in rat lungs. J Immunol 172: 2569-77.
37. Marderstein EL, Bucher B, Guo Z, Feng X, Reid K, Geller DA, (2003) Protection of rat hepatocytes from apoptosis by inhibition of c-Jun N-terminal kinase. Surgery 134: 280-4.
38. Lee KH, Kim SE, Lee YS, (2006) SP600125, a selective JNK inhibitor, aggravates hepatic ischemia-reperfusion injury, Exp. Mol. Med. 38:408-4 16.
39. Furukawa M, Ebmeyer J, Pak K, Austin DA, Melhus A, Webster NJ, Ryan AF, (2007) Jun N-terminal protein kinase enhances middle ear mucosal proliferation during bacterial otitis media Infec Immun 75: 2562-71.